Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment: A crossover, randomised, double-blinded, placebo-controlled study (Retraction of vol 31, pg 35, 2014)

被引：3
|
作者：
Wetzel, Leonore
Zadrazil, Markus
Paternostro-Sluga, Tatjana
Authried, Georg
Kozek-Langenecker, Sibylle
Scharbert, Gisela
机构：
来源：
EUROPEAN JOURNAL OF ANAESTHESIOLOGY | 2015年 / 32卷 / 04期
关键词：
D O I：
10.1097/EJA.0000000000000244
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [1] RETRACTED: Intravenous nonopioid analgesic drugs in chronic low back pain patients on chronic opioid treatment A crossover, randomised, double-blinded, placebo-controlled study (Retracted article. See vol. 32, pg. 287, 2015)
    Wetzel, Leonore
    Zadrazil, Markus
    Paternostro-Sluga, Tatjana
    Authried, Georg
    Kozek-Langenecker, Sibylle
    Scharbert, Gisela
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2014, 31 (01) : 35 - 40
  • [2] A double-blinded randomised controlled study of the value of sequential intravenous and oral magnesium therapy in patients with chronic low back pain with a neuropathic component
    Yousef, A. A.
    Al-deeb, A. E.
    ANAESTHESIA, 2013, 68 (03) : 260 - 266
  • [3] Intravenous infusion of phenytoin relieves neuropathic pain: A randomized, double-blinded, placebo-controlled, crossover study
    McCleane, GJ
    ANESTHESIA AND ANALGESIA, 1999, 89 (04): : 985 - 988
  • [4] Intravenous infusion of phenytoin reliees neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study
    Gehling, M
    Tryba, M
    SCHMERZ, 2000, 14 (06): : 437 - 438
  • [5] Exploring electroencephalographic infraslow neurofeedback treatment for chronic low back pain: a double-blinded safety and feasibility randomized placebo-controlled trial
    Adhia, Divya Bharatkumar
    Mani, Ramakrishnan
    Mathew, Jerin
    O'Leary, Finella
    Smith, Mark
    Vanneste, Sven
    De Ridder, Dirk
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [6] Exploring electroencephalographic infraslow neurofeedback treatment for chronic low back pain: a double-blinded safety and feasibility randomized placebo-controlled trial
    Divya Bharatkumar Adhia
    Ramakrishnan Mani
    Jerin Mathew
    Finella O’Leary
    Mark Smith
    Sven Vanneste
    Dirk De Ridder
    Scientific Reports, 13
  • [7] Magnitude, response, and psychological determinants of placebo effects in chronic low-back pain: a randomised, double-blinded, controlled trial
    Finniss, Damien
    Nicholas, Michael
    Brooker, Charles
    Cousins, Michael
    Benedetti, Fabrizio
    PAIN REPORTS, 2019, 4 (03)
  • [8] Double-blinded placebo-controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B
    Chan, HLY
    Sung, JJY
    Fong, WF
    Chim, AML
    Yung, PP
    Hui, AY
    Fung, KP
    Leung, PC
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (03) : 339 - 345
  • [9] Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial)
    Juel, Jacob
    Olesen, Soren Schou
    Olesen, Anne Estrup
    Poulsen, Jakob Lykke
    Dahan, Albert
    Wilder-Smith, Oliver
    Madzak, Adnan
    Frokjaer, Jens Brondum
    Drewes, Asbjorn Mohr
    BMJ OPEN, 2015, 5 (03):
  • [10] Analgesic tolerance without demonstrable opioid-induced hyperalgesia: a double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain
    Chu, Larry F.
    D'Arcy, Nicole
    Brady, Caitlin
    Zamora, Abigail Kathleen
    Young, Chelsea Anne
    Kim, Julie Eunwoo
    Clemenson, Anna Marie
    Angst, Martin S.
    Clark, J. David
    PAIN, 2012, 153 (08) : 1583 - 1592
12345